J. Racketa

Impact of the severity of vasomotor symptoms on health status, resource use, and productivity

Jennifer Whiteley, Jan-Samuel Wagner, Andrew G. Bushmakin et al. · Menopause The Journal of The North American Menopause Society · 2013 · 136 citations

Modeling effects of <scp>SGLT</scp>‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes

Julia Dziuba, Peter Alperin, J. Racketa et al. · Diabetes Obesity and Metabolism · 2014 · 96 citations

Evaluation of the Efficacy and Safety of Bazedoxifene/Conjugated Estrogens for Secondary Outcomes Including Vasomotor Symptoms in Postmenopausal Women by Years Since Menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) Trials

JoAnn V. Pinkerton, Lucy Abraham, Andrew G. Bushmakin et al. · Journal of Women s Health · 2013 · 51 citations

Selective Estrogens, Gynecology, Menopausal Hormone Therapy +21

Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens

JoAnn V. Pinkerton, Kaijie Pan, Lucy Abraham et al. · Menopause The Journal of The North American Menopause Society · 2013 · 51 citations

Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study

Francesco Blasi, Helmut Ostermann, J. Racketa et al. · Respiratory Research · 2014 · 29 citations · Full text

Community-acquired Pneumonia, Clinical Epidemiology, Respiratory Infection +5